Alphaviral Vector Cell Lines for Stable Protein Expression
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current alphaviral vector systems for expressing genes in mammalian cells face challenges such as cytopathicity, mutation accumulation, and variable expression levels, limiting their ability to produce recombinant proteins stably and at high levels.
Innovation Solution
A polynucleotide comprising a minimal albumin promoter with a DNA sequence complementary to an alphavirus replicon, integrated into the cell genome, and flanked by site-specific recombinase recognition sequences, allowing for regulable expression and easy exchange of genes using recombinase-mediated cassette exchange.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If alphaviral vectors are used for gene expression in mammalian cells, then high-level protein expression is achieved, but cytopathicity occurs limiting long-lasting expression
Solution Approach 1:
The patent extracts and removes the structural genes (capsid, envelope, 6K) from the alphavirus replicon, retaining only the non-structural replicase genes and essential replication elements. This creates a replicon-based expression system that maintains high protein expression while eliminating cytopathic effects caused by viral structural proteins, enabling long-lasting stable expression in mammalian cells
Solution Approach 2:
The patent uses a DNA sequence complementary to the alphavirus replicon as an intermediary element that can be integrated into the host cell genome. This complementary DNA sequence serves as a template for generating the RNA replicon in trans, mediating between the stable integrated DNA and the active RNA replication machinery, thereby ensuring both genomic stability and sustained high-level expression
2Reliability
If non-cytopathic alphavirus mutants are used, then long-lasting expression is achieved, but expression levels drop to about 4% of original SIN vector
Solution Approach 1:
The patent introduces specific point mutations in the nsp2 protein (P718T and R649H) that alter the replicase function to reduce cytopathicity while maintaining replication efficiency. These parameter changes in the replicase enzyme allow the system to achieve both long-lasting expression and high expression levels, overcoming the trade-off observed in previous mutants
3Reliability
If constitutive expression from integrated replicon is used, then stable cell lines are generated, but mutation accumulation occurs due to constant viral replicase copying
Solution Approach 1:
The patent implements inducible expression systems using tetracycline-responsive elements (TRE) that allow dynamic control of replicon activity. The viral replicase is expressed only when induced by tetracycline or doxycycline, rather than constitutively. This dynamic control prevents mutation accumulation during cell passage while maintaining the ability to generate stable cell lines with high expression when needed
4Reliability
If antibiotic selection is used to maintain replicon expression, then stable cell lines are obtained, but cells adapt requiring smaller replicon amounts decreasing expression levels
Solution Approach 1:
The patent employs inducible expression systems with tetracycline-responsive elements that provide feedback control of replicon activity. Instead of relying on antibiotic selection that leads to adaptive downregulation, the system allows researchers to induce high-level expression only when needed, maintaining full replicon functionality and expression capacity without selective pressure-driven adaptation
Data Source
Figure 1~2
Figure 3A~3B
Figure 3C~3D
AI summary
The present invention relates to polynucleotides and alphaviral vectors for the expression of genes of interest in mammalian cells. Additionally, the invention relates to cells which comprise said polynucleotides and alphaviral vectors and are capable of stably expressing one or more genes of interest. The invention also relates to methods for obtaining said cells, to methods for expressing a gene of interest in said cells, and to methods for replacing the gene of interest stably expressed by said cells with another gene of interest.